UAE In-Vitro Diagnostics Devices Market Overview
Base Year: 2024
Historical Years: 2019-2024
Forecast Years: 2025-2033
Market Growth Rate: 4.34% (2025-2033)
The UAE in-vitro diagnostics (IVD) devices market is experiencing significant growth, driven by advancements in healthcare technology, rising demand for early disease detection, and increasing investments in medical infrastructure. According to the latest report by IMARC Group, The UAE in-vitro diagnostics (IVD) devices market size reached USD 287.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 429.4 Million by 2033, exhibiting a growth rate (CAGR) of 4.34% during 2025-2033.
UAE In-Vitro Diagnostics Devices Industry Trends and Drivers:
The rise in chronic diseases, like diabetes and heart issues, boosts the need for in-vitro diagnostics (IVD) in the UAE. A greater focus on preventive healthcare and early detection drives market growth. Government efforts to improve healthcare infrastructure and expand diagnostic services support this growth. More people understand the importance of accurate diagnoses, which increases the use of advanced IVD technologies. The demand for point-of-care testing (POCT) devices makes diagnostic services more accessible and convenient. Advances in molecular diagnostics and immunodiagnostics improve testing accuracy and sensitivity. Increased investments in research and development of innovative IVD solutions strengthen the market.
The demand for personalized medicine and targeted therapies is growing. This needs advanced diagnostic tools. Automation and digitalization in labs improve efficiency and cut turnaround time. The private healthcare sector and medical tourism boost the need for high-quality IVD devices. Government support for healthcare innovation and tech adoption helps the market grow. A focus on quality control and regulatory compliance increases demand for certified IVD products. There’s also a rising need for home testing solutions and remote monitoring devices, which diversifies the market. Strategic partnerships between local and international companies aid in technology transfer and market access.
Grab a sample PDF of this report: https://www.imarcgroup.com/uae-in-vitro-diagnostics-market/requestsample
UAE In-Vitro Diagnostics Devices Industry Segmentation:
The report has segmented the market into the following categories:
Breakup by Application:
- Infectious Diseases
- Diabetes
- Blood Test
- Nephrology
- Cardiology
- Oncology
- Autoimmune Diseases
- Others
Breakup by End-User:
- Hospital-Based Centres
- Diagnostics Chains
- Standalone Centres
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Key highlights of the Report:
- Market Performance (2019-2024)
- Market Outlook (2025-2033)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
